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Abstract
Overexpression of miRNA, miR-24, in mouse hematopoietic progenitors increases mono-
cytic/ granulocytic differentiation and inhibits B cell development. To determine if endoge-
nous miR-24 is required for hematopoiesis, we antagonized miR-24 in mouse embryonic
stem cells (ESCs) and performed in vitro differentiations. Suppression of miR-24 resulted in
an inability to produce blood and hematopoietic progenitors (HPCs) from ESCs. The pheno-
type is not a general defect in mesoderm production since we observe production of na-
scent mesoderm as well as mesoderm derived cardiac muscle and endothelial cells.
Results from blast colony forming cell (BL-CFC) assays demonstrate that miR-24 is not re-
quired for generation of the hemangioblast, the mesoderm progenitor that gives rise to
blood and endothelial cells. However, expression of the transcription factors Runx1 and Scl
is greatly reduced, suggesting an impaired ability of the hemangioblast to differentiate. Last-
ly, we observed that known miR-24 target, Trib3, is upregulated in the miR-24 antagonized
embryoid bodies (EBs). Overexpression of Trib3 alone in ESCs was able to decrease HPC
production, though not as great as seen with miR-24 knockdown. These results demon-
strate an essential role for miR-24 in the hematopoietic differentiation of ESCs. Although
many miRNAs have been implicated in regulation of hematopoiesis, this is the first miRNA
observed to be required for the specification of mammalian blood progenitors from
early mesoderm.
Author Summary
Studies of mouse embryos and embryonic stem cells (ESCs) have defined the ontogeny of
mammalian embryonic hematopoietic cells. The ESC differentiation system has been valu-
able for dissecting the molecular regulation of the development of mesoderm into HPCs.
Extracellular signals regulate a complex network of transcription factors to direct embry-
onic hematopoietic development. Mammalian miRNAs have previously not been
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described to regulate this genetic network during embryonic hematopoiesis. However, a
role for miRNAs in producing the hemangioblast, and hemogenic endothelium in Xeno-
pus has been described. Our work with ESCs demonstrates a specific requirement for the
miRNA, miR-24, in the development of hematopoietic progenitors cells (HPCs). Antago-
nizing miR-24 in ESCs does not affect generation of BL-CFCs, the in vitro equivalent of
the hemangioblast, but does compromise the ability of those BL-CFCs to produced HPCs.
Expression of transcription factors required for HPC production downstream of the
hemangioblast, Scl, and Runx1, is greatly reduced by antagonizing miR-24. These results
identify miR-24, as a mammalian miRNA required for the development of blood from
newly formed mesoderm.
Introduction
MicroRNAs (miRNAs) are small (~22 nucleotide) RNA molecules that regulate gene expres-
sion post-transcriptionally. They are implicated in important cellular processes such as apopto-
sis, proliferation, and differentiation [1]. Work from many laboratories, including our own,
shows that miRNAs regulate hematopoietic progenitor cell fate decisions and immune cell
function [2–4]. However, the role of miRNAs in regulating the earliest hematopoietic stem and
progenitor cell development is less characterized. Additionally, a role for miRNAs has not
been described for directing the development of the mammalian hemangioblast or hemogenic
endothelium, the early mesoderm that gives rise to primitive and definitive hematopoietic cells
[5, 6].
Studies of mouse embryos and embryonic stem cells (ESCs) have defined the ontogeny of
mammalian embryonic hematopoietic cells [7]. During embryogenesis primitive hematopoiet-
ic progenitor cells (HPCs) are produced first in the yolk sac, and then in the embryo proper.
Definitive hematopoiesis begins in the aorta-gonad-mesenephros (AGM) region off the em-
bryo, and later switches to the fetal liver. These tissues arise from a subset of mesoderm, the lat-
eral plate mesoderm. In vertebrates, the initial hematopoietic and endothelial lineages are
generated simultaneously in the same region of the embryo [8, 9]. This suggests that these line-
ages arise from a common mesodermal derived progenitor termed the hemangioblast. The first
direct evidence demonstrating the existence of the hypothesized hemangioblast came from
work with ESCs. Keller and colleagues identified a progenitor from ESC derived embryoid bod-
ies (EBs) that formed a blast colony in methylcellulose, which contained clonal blood and en-
dothelial cells [10]. They termed this progenitor the blast colony-forming cell (BL-CFC), which
was proposed to be the in vitro equivalent of the hemangioblast. These progenitors were en-
riched in the EB population of cells that coexpresses the mesoderm specific transcription factor
T (Brachyury), and the tyrosine kinase receptor Flk1 [11]. This same group later demonstrated
the transient existence of BL-CFCs in the gastrulating mouse embryo within the primitive
streak [12]. In the aortic-gonad-mesenephros (AGM) region of the mouse embryo, blood has
been shown to arise from differentiated endothelial cells termed the hemogenic endothelium,
which appears independent of a hemangioblast cell [13, 14]. During differentiation of ES de-
rived BL-CFCs, it has also been observed that BL-CFC cells form a hemogenic endothelium in-
termediate during the development of HPCs [5].
The ESC differentiation system has been valuable for dissecting the molecular regulation of
the development of mesoderm into HPCs. Extracellular signals including BMPs, FGFs, VEGF,
Notch ligands, and Wnts [15–18] regulate a complex network of transcription factors to direct
embryonic hematopoietic development. The Ets transcription factor Etv2 is essentially for
MiR-24 Is Necessary for Hematopoiesis
PLOS Genetics | DOI:10.1371/journal.pgen.1004959 January 29, 2015 2 / 22
Competing Interests: The authors have declared
that no competing interests exist.
hemangioblast specification in zebrafish [19, 20]. A direct connection to mammalian heman-
gioblast development has not been shown, but Etv2 is necessary for development of embryonic
blood progenitors and vasculature as demonstrated by mouse gene targeting experiments [21].
Etv2 expression is correlated with markers of hemangioblast and hemogenic endothelium in
differentiating ESCs, and genetically acts upstream of the transcription factor Scl in blood de-
velopment [22, 23]. Scl is required for the differentiation of BL-CFC cells into hemogenic endo-
thelium [5, 24]. After formation of hemogenic endothelium, another transcription factor,
Runx1, is required for the production of definitive HPCs [5, 25]. These signaling pathways,
and transcription factors are known to regulate and/or be regulated by miRNAs, so it would be
surprising if miRNAs did not have a role in the production of HPCs for mesoderm [26–29].
Additionally, global knockdown of miRNAs in Xenopus embryos results in an ablation of
hemangioblast development [30].
We recently identified miR-24 as a miRNA that regulates the development of adult hemato-
poietic progenitor cells [3]. MiR-24 is produced from two distinct mammalian genesmirn23a,
andmirn23b. Themirn23a gene codes for three miRNAs, miR-23a, miR-27a, and miR-24–2,
which is expressed as a pri-miRNA from its own independent transcription unit.Mirn23b
codes for miRs-23b, -27b, and 24–1, and is embedded in an intron of the aminopeptidase O
(AMPO) gene. The mature miR-24 miRNAs (miRs-24–1, -24–2) produced from both clusters
are identical in sequence whereas the mature miRs-23a/b and-27a/b differ by one nucleotide at
the 3 prime ends (outside of the seed sequence which is responsible for target selection). The
mirn23amiRNAs are enriched in hematopoietic cells compared tomirn23bmiRNAs [3].
When we retrovirally expressed the miRs-23a, 27a, and 24 in hematopoietic progenitors we ob-
served that these miRNAs inhibited B cell development and potentiated the development of
monocytes and granulocytes [3]. Additionally, we observed that miR-24 is necessary and suffi-
cient to generate this phenotype.
To determine if miR-24 is required for proper monocyte and granulocyte development, we
antagonized miR-24 in murine embryonic stem cells (ESCs) by infecting them with a lentivirus
encoding an shRNA targeting miR-24. Stable knockdown clones were differentiated into em-
bryoid bodies (EBs). To our surprise, hematopoiesis was dramatically inhibited in miR-24
knockdown (KD) EBs. In this report we examine the requirement for miR-24 in blood develop-
ment from ESCs. In addition, we interrogated Trib3 as a critical target for miR-24 to repress
during the development of HPCs. Previously; Trib3 was identified as a direct miR-24 target in
vascular smooth muscle cells [31]. Trib3 modulates BMP/ Smad signaling through inhibition
of the E3 ubiquitin ligase Smurf1 [32], that negatively regulates Smad1 and Smad 5. MiR-24
targeting of Trib3 potentially links it to known pathways regulating embryonic hematopoiesis
[33–36].
Results
MiR-24 is required for blood formation from embryonic stem cells
Previously, we demonstrated that enforced expression of miR-24 in hematopoietic progenitors
promoted myeloid (monocytes and granulocytes) development [3]. To determine if miR-24 is
required for the development of myeloid cells, we infected mouse ESCs with a lentivirus ex-
pressing an shRNA that binds and inhibits miR-24 (miArrest-24, Genecopoeia, Rockville,
MD). For controls, we generated ESCs expressing a scrambled non-targeting shRNA. The
miR-24 shRNA clones had reduced expression of miR-24 that persisted for at least 6 days of
EB differentiation as determined by quantitative reverse transcriptase PCR (Q-RT-PCR) (S1A,
B Fig.). Decreased expression of miR-24 may underestimate the reduction in miR-24 as we
may detect miR-24 bound inactive to the shRNA. MiR-24 knockdown did not affect the
MiR-24 Is Necessary for Hematopoiesis
PLOS Genetics | DOI:10.1371/journal.pgen.1004959 January 29, 2015 3 / 22
expression of clustered miRNAs, miRs-23a and 27a (S1C Fig.). When ESC lines were differenti-
ated, we observed that, in contrast to wildtype and scrambled control shRNA expressing ESCs
(Fig. 1A); the miR-24 knockdown clones did not generate EBs with hemoglobinized cells
(Fig. 1B). This suggested that blood was not being made and this was confirmed by a dramatic
reduction in the expression of hematopoietic transcription factors Gata1 (P<0.0005) and Sfpi1
(P<0.0008) in miR-24 KD d6 EBs compared to wildtype and scrambled control derived EBs
(Fig. 1C). We also performed hematopoietic colony assays with cells isolated from d9 EBs as
previously described [37]. On average we observed less than 1 hematopoietic colony generated
from 50 miR-24 knockdown EBs (S2 Fig.). To support the conclusion that the hematopoietic
defect is due specifically to knockdown of miR-24, we also generated miR-24 knockdown ESCs
with an independent shRNA expressing lentiviral vector (miRZIP, Systems Biosciences, Moun-
tain View, CA). A similar defect in blood production in EBs was observed using this alternative
method of targeting miR-24 (S3A, S3B Figs.).
Fig 1. MiR-24 is required for blood development frommouse embryonic stem cells. ESC clones were generated from RW4 cells infected with either
miArrest-24 (ShRNA targeting miR-24) or miArrest-SCR (Scrambled shRNA) lentivirus. A)RW4 wildtype, SCR (miArrest-SCR), andB)miArrest-24 clones
(24–1, 24–6B, and 24–14B) were differentiated into EBs for 14d in methylcellulose media. Top 3 panels are 25X magnification, and bottom panels are 50X.
C)Quantitative RT-PCR analysis of expression of the hematopoietic transcription factors Gata1, and Sfpi1 from RNA obtained from the indicated ESC clones
differentiated into EBs in liquid culture for 6d. The decrease in expression observed in the miArrest-24 clones compared to uninfected and miArrest-SCR
infected RW4 clones was significant for Gata1, and Sfpi1 with respective P values of<0.0005, and<0.0008 as determined by unpaired t-test. Error bars
represent the standard error of the mean (SEM).
doi:10.1371/journal.pgen.1004959.g001
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MiR-24 is required for the generation of hematopoietic progenitor cells
We observed that miR-24 was necessary for blood development [3]. To determine if this re-
quirement was early or late in embryonic hematopoiesis, we performed flow cytometry on cells
derived from d6 EBs to determine if HPCs were being made in the absence of miR-24. EBs gen-
erate HPCs that can be identified by the cell surface expression of CD41 [38]. There were al-
most no HPCs derived from miR-24 KD clones (Figs. 2A, S4). A similar defect in HPC
production was observed from ESCs with miR-24 targeted by the miRZIP lentiviral vector
(S3C Fig.). Consistent with this result, we observed significantly decreased expression of the
transcription factors Scl and Runx1 between wildtype/ scrambled controls and miR-24 KD
clones in d4 EBs with respective P values of less than 0.007, and 0.002, as well as at d6 with
P values of less than 0.003, and 0.008 (Fig. 2B, C). These two factors are expressed in HPCs and
function downstream of the hemangioblast [24, 25].
Absence of miR-24 does not result in a general differentiation defect
The defect in hematopoiesis could be due to a global defect in development. To examine if
early germ layer tissue was being formed from miR-24 KD ESCs, 2 scrambled control, and 2
miR-24 KD clones were differentiated and RNA harvested at d3 and d4. Q-RT-PCR analyzed
expression of Pax6 (Ectoderm), FoxA2 (Endoderm), and T (Brachyury, mesoderm). No signifi-
cant differences (P>0.05) in the expression of these genes were observed when comparing the
average values obtained from scrambled and miR-24 KD clones (Fig. 3A). Hematopoietic cells
in the developing EB and embryos are derived from mesoderm tissue. Mesoderm gives rise to
paraxial and lateral plate mesoderm with the later giving rise to hematopoietic cells. To deter-
mine if there was a defect in nascent mesoderm differentiation we analyzed expression of the
genes Twist (lateral plate) and Tbx6 (paraxial). We did not observe a significant effect of miR-
24 knockdown on Tbx6 expression, though expression was variable within control and 24 KD
clones. MiR-24 antagonism did lead to a significant decrease in Twist expression at both d3
(P<0.002) and d4 (P< 10-8)(Fig. 3B). This suggested a reduction in lateral plate mesoderm,
consistent with the observed decrease in hematopoiesis. To further investigate this, we per-
formed flow cytometry analysis of d4 EBs to determine if early mesoderm populations were
being made in miR-24 KD clones. Lateral plate mesoderm is identified by the cell surface ex-
pression of FLK1, and the lack of expression of PDGFRα. In contrast, paraxial mesoderm is
identified by expression of PDGFRα and lack of expression of FLK1 [39, 40]. Nascent meso-
derm coexpresses both FLK1, and PDGFRα, and can give rise to either lateral plate or paraxial
mesoderm. By flow cytometry, we did not observe a defect in mesoderm production, as lateral
plate (FLK1+PDGFRα-) and paraxial mesoderm (FLK1-PDGFRα+) were observed in miR-24
KD EBs (Fig. 3C).
Besides blood, lateral plate mesoderm is responsible for the production of cardiac muscle
and blood vessels (endothelial cells). To examine production of blood vessels we performed
vascular sprout assays [41]. Forty d6 miR24 KD EBs and control-scrambled shRNA EBs were
plated onto collagen-coated plates in media containing angiogenic cytokines. Sprout formation
was assessed 6 days later (total 12 days of culture). EBs were scored in blinded fashion accord-
ing to 4 standard classes based on vascular sprout formation: I- no sprout formation, II- few
sprouts, III- many sprouts but no network, IV- many sprouts with network [41]. In the devel-
opment of class 3 and 4 sprouts, we saw large variability between the two miR-24 KD clones ex-
amined (Fig. 4A). However there was a slight decrease in the generation of class 4 sprouts
between miR-24 KD and control ESC clones, which was statistically significant (P<0.002). The
sprouts on individual EBs appeared morphological similar between control and MiR-24 KD
EBs (Fig. 4B). We also analyzed expression of Pecam1 (CD31) to evaluate blood vessel/
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Fig 2. MiR-24 is required for HPC generation. ESC clones infected with control miArrest-SCR, or miArrest-
24 lentivirus were differentiated into EBs for 6d in liquid culture and analyzed by flow cytometry and
quantitative RT-PCR. A) Flow cytometry analysis of CD41 and cKit (CD117) cell surface expression on single
cells isolated from EBs generated from the indicated ESC clones. CD41+cKit- population contains primitive
HPCs and CD41+cKit+ contains primitive and definitive HPCs.B, C) Expression of the transcription factors
B) Scl, andC) Runx1, which are required for the development and/or function of hemogenic endothelium.
RNA was isolated from d4 and d6 EBs. The decrease in expression observed in the miArrest-24 clones
compared to uninfected and miArrest-SCR infected RW4 cells was significant at d4 for Scl, and Runx1 with
respective P values of<0.007, and<0.002, as well as at d6 with respective P values of<0.003, and<0.008.
P values were determined by unpaired t-test. Error bars represent the SEM.
doi:10.1371/journal.pgen.1004959.g002
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endothelial cell development. Pecam1 expression was evaluated in d4, d8, and d12 EBs. Initially
Pecam1 expression was decreased between miR-24 KD and control EBs at d4 (P<0.0002)
(Fig. 4C). However by d8 and d12, there are no longer any significant differences in Pecam1 ex-
pression (P>0.05). We also examined the expression of endothelial gene Tie2 at d8 and d12 of
EB differentiation. There was no significant difference in Tie2 at d8, however there was a small
increase in Tie2 detected in the miR-24KD clones at d12 (P<0.0007) (Fig. 4D).
To assay cardiac development, we generated EBs by hanging drop and then replated indi-
vidual EBs into single wells of a 96 well plate. After 5d cardiac muscle differentiation was evalu-
ated by determining the percentage of wells positive for contracting cells. We did not observe a
significant difference in the frequency of wells positive for beating EBs in the miR-24 KD cul-
tures compared to control cultures (Fig. 5A). We also assayed expression of cardiac muscle
genes Nkx2.5, and Mef2c between control EBs (wildtype and Scrambled) and miR-24 KD
clones. Our analysis did not demonstrate any significant differences in the expression of these
Fig 3. MiR-24 is not required for the differentiation of embryonic stem cells into embryoid bodies. Two independently derived miArrest-SCR, and
miArrest-24 ESC clones were differentiated into EBs. RNA was collected at d3 and d4 of differentiation, and used to analyze gene expression by quantitative
RT-PCR.A) Formation of the germ layers was analyzed by assaying expression of Pax6 (Ectoderm), FoxA2 (Endoderm), and T (Mesoderm). No significant
differences were observed in gene expression comparing scrambled shRNA clones to miR-24 shRNA clones.B) To further analyze mesoderm differentiation
the expression of lateral plate mesoderm gene Twist, and paraxial plate mesoderm gene Tbx6 were assayed. No significant difference was observed in Tbx6
expression, however the decrease in Twist expression was significant at d3 and d4 with respective P values of<0.002, and<10-8 respectively. Error bars in
panels A and B represent the SEM.C. The indicated ESC clones were differentiated in liquid culture for 4d. Development of paraxial and lateral plate
mesoderm was analyzed by flow cytometry. Lateral plate mesoderm is FLK+PDGFRα-, paraxial mesoderm is FLK1-PDGFRα+, and nascent uncommitted
mesoderm is FLK1+PDGFRα+.
doi:10.1371/journal.pgen.1004959.g003
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two genes (Fig. 5B,C). Mef2c expression does appear to be decreased if we just compare the
miR-24 KD clones to the scrambled control clone.
Perturbation of miR-24 does not effect generation of blast colony-foming
cells
Since there was not a general defect in mesoderm production, we further investigated when in
HPC development miR-24 is required. Although lateral pate mesoderm is diminished as
Fig 4. Endothelial cell development impaired in miR-24 knockdown embryoid bodies. A)D11 EBs plated in collagen with angiogenic growth factors for
an additional 4d were scored according to 4 standard classes of vascular sprout formation: I- no sprout formation, II- few sprouts, III- many sprouts but no
network, IV- many sprouts with network [37]. The decrease in class 4 sprouts observed in miR-24 knockdown clones, 24–1, and 24–6B compared to RW4,
and SCR shRNA control clones is significant with a P value<0.002.B)Day 11 EBs differentiated additional 4 days in collagen media. Representative image
of sprouting from control and miR-24 KD EBs. Bar denotes 400uM.C) Expression of endothelial gene Pecam1 (CD31) in RNA isolated from d4, d8, and d12
EBs. The decrease in expression observed at d4 in the miArrest-24 clones compared to uninfected and miArrest-SCR infected RW4 was significant for
Pecam1 with a P value of<0.0002 as determined by unpaired t-test. Significant differences were not observed at d8 or d12.D) Expression of endothelial
associated gene Tie2 was analyzed at d8 and d12 of EB development. No differences in Tie2 expression were observed at d8, however there was a slight
increase in Tie2 expression at d12 with P<0.0007 as determined by unpaired t-test. Error bars represent the SEM.
doi:10.1371/journal.pgen.1004959.g004
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evaluated by Twist expression, it does develop as observed by flow cytometry (FLK1/PDGFRα)
and assaying cardiac and vascular sprout development. We performed BL-CFC assays with pa-
rental RW4 cells, scrambled shRNA clones and miR-24 shRNA clones. ESCs were differentiat-
ed into EBs for either 2.75d or 3.0d, and dissociated into single cell suspensions. The cells were
then cultured in methylcellulose media for 4 days and BL-CFC colonies counted (Fig. 6) [42,
43]. Compared to RW4 cells we observed that scrambled and miR-24 KD clones had a reduced
ability to make BL-CFCs. There was no difference in the production of BL-CFCs from scram-
bled and miR-24 shRNA expressing clones at d2.75 (Fig. 6A). From d3 EBs we observed a slight
but significant increase (P<0.0007) in BL-CFCs obtained from miR-24 KD clones compared to
Fig 5. MiR-24 is not required in EBs for cardiac muscle development. A) RW4 parental cells, miArrest-
Scr ESC clones, and miArrest-24 ESC clones were differentiated into EBs and by hanging drop and
individual EBs were transferred to 96 well plate. After 5 days the wells were examined for the presence of
beating cells indicative of the presence of cardiac muscle. For each individual differentiation the percent wells
positive for beating cells was recorded. RW4 cells n = 6, miArrest-Scr n = 8, and miArrest-24 n = 16. For
miArrest-Scr, 2 independent clones were examined, and for miArrest-24, 6 independent clones were
examined. B, C)Quantitative RT-PCR analysis of expression of the cardiac muscle transcription factorsB)
Mef2c, andC) Nkx2.5. For both Mef2c, and Nkx2.5 the differences in expression observed in the miArrest-24
clones compared to uninfected and miArrest-SCR infected clones wasNOT considered significant with P
values>0.05 as determined by unpaired t-test. Error bars represent the SEM.
doi:10.1371/journal.pgen.1004959.g005
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scrambled control clones (Fig. 6B). However the number of BL-CFCs obtained from the miR-
24 KD cells was lower than the numbers observed with wildtype cells.
To determine if the BL-CFC colonies were identical between controls and miR-24 KD cul-
tures, we examined gene expression in the BL-CFC colonies. Twenty colonies from each cul-
ture were picked for generation of cDNA, and then individual gene expression was analyzed by
Q-RT-PCR. Consistent with the EB results (Figs. 1C, 2B, 2C), there is a dramatic decrease in
the expression of Gata1, Runx1, and Scl in the miR-24 KD BL-CFCs compared to control
scrambled shRNA expressing clones (Fig. 6D). However endothelial genes Cdh5 (Ve-
Cadherin), and Pecam1 were expressed similarly between control and miR-24 KD cultures.
This suggests that there is a defect in the development of hemogenic endothelium, or the differ-
entiation of hemogenic endothelium into blood. We attempted to determine if hemogenic en-
dothelium was being produced by culturing Flk1+ cells, and analyzing by flow cytometry for
the markers Tie2, and cKit according to the methods of Lancrin et al. [5]but were unable to
generate sufficient number of differentiated cells to make any conclusions.
We also analyzed the expression of the transcription factor Etv2 to evaluate early hemato-
poietic progenitor generation. RNA was isolated from d3, d4, and d5 EBs. As previously ob-
served Etv2 expression initially increases with wildtype EB differentiation and then decreases
[21]. We observed a significant decrease in Etv2 expression between control clones and the
Fig 6. BL-CFCs develop from EBs with antagonized miR-24.RW4 parental cells, miArrest-Scr clones, and miArrest-24 clones were differentiated in liquid
culture for A) 2.75d or B) 3.0d. EBs were dissociated into single cell suspensions and plated in methylcellulose for growth of BL-CFCs. 4d later BL-CFCs
were counted. 2 independent miArrest-Scr clones were examined for d2.75 and d3 differentiations. 4 miArrest-24 clones for d2.75 and 7 miArrest-24 clones
for d3 were examined. For d2.75, RW4 n = 4, miArrest Scr n = 6, and miArrest-24 n = 8. For d3.0, RW4 n = 8, miArrest Scr n = 8, and miArrest-24 n = 16.C)
RNA was isolated from d3, d4, and d5 EBs derived from the indicated ESC clones. Expression of the transcription factor Etv2 was examined. The decrease
in expression observed in the miArrest-24 clones compared to uninfected and miArrest-SCR infected RW4 cells was significant at d3 (P<0.006), d4
(P<0.002), and d5 (P<0.006) as determined with by unpaired t-test. D) Twenty BL-CFC colonies from individual cultures were isolated and used to generate
cDNA. Quantitative-RT-PCR was performed with the indicated gene specific primers. Data was averaged from results obtained from the differentiation of 3
scrambled clones, and 3 mir-24 KD clones. The decreases in Gata1, Runx1, and Scl expression are significant with respective P values of P<0.001, P< 10-4,
and P<10-7.
doi:10.1371/journal.pgen.1004959.g006
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miR-24KD clones at all time points (Fig. 6C). However Etv2 was reduced approximately 50%
which was not as dramatic a reduction as observed with the downstream factor Scl (Fig. 2B).
Expression of the gene encoding pre-miR-24–2 enhances hematopoietic development of
d3 EB derived cells. The BL-CFC (hemangioblast) is present in the T positive FLK1+ fraction
of the differentiating EBs [11]. From d4 EBs generated from an ESC line with GFP knocked-in
to the T locus we isolated T- (GFP-)/Flk1-, T+ (GFP+)/Flk1-, and T+ (GFP+)/Flk1+ cells by
FACs (Figs. 7A, S5). RNA was prepared from the isolated cell population and the validity of
the sort was examined by assaying the expression of genes known to be associated with each
fraction (S5 Fig.)[11]. Q-RT-PCR was performed with RNA extracted from the isolated frac-
tions to examine the relative levels of mature mirn23a/ mirn23b miRNAs: miR-24, mir-23a,
miR23b, miR-27a, and miR-27b (Fig. 7B, 7C). MiR-24 was enriched in the mesoderm T+
(GFP+)/Flk1- fraction. MiR-24 decreased in the T+ (GFP+)/Flk1+ cells, the least expression was
Fig 7. Expression of the gene encodingmiR-24–2 enhances hematopoietic development in EBs. A) ESCs with GFP knocked in to the T locus
(Brachyury) were differentiated for 4d into EBs. The EBs were dissociated into single cells suspensions, and sorted into GFP-Flk1-, GFP+/Flk1-, and GFP
+Flk1+ fractions.B) The mirn23a miRNAs, miR-23a, 24–2, and 27a are clustered on mouse chromosome 8 and transcribed from an independent
transcription unit. The mirn23b miRNAs, miR-23b, 24–1, and 27b are clustered on mouse chromosome 13 and are embedded in an intron of aminopeptidase
O. C)RNA was isolated from the fractions diagrammed in panel A and used to evaluate the relative expression of the mature mirn23a, and mirn23b miRNAs
in the fractions. Expression levels shown are relative to the GFP-/Flk1- (DN) fraction.D) D3 EB cells were infected with MSCV control or MSCV-mirn23a
retrovirus, and reformed into EBs by hanging drop. The EBs were cultured an additional 5 days and contribution of the infected (GFP+) cells to the HPC
population (CD41+, and CD41+cKit+) was evaluated. E) Three independent transductions, and subsequent differentiation were performed. The average
percent of CD41+ HPCs is shown. The increase in CD41+ cells in the MSCV-mirn23a transduced cultures was significant with P<0.008 as determined by
unpaired t-test.
doi:10.1371/journal.pgen.1004959.g007
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observed in the double negative fraction. A similar pattern was seen with miRs-23a, and 27a.
However expression of miR-23b and miR-27b was highest in the double negative fraction with
lowest levels expressed in the T+ (GFP+)/Flk1+ fraction.
Since endogenous mirn23a gene expression increased in mesoderm tissue fated to become
hematopoietic tissue, we overexpressed it via retrovirus in differentiating ESCs to determine if
exogenous expression could enhance hematopoietic development. We hypothesized that in
order for mirn23a to enhance hematopoietic development that it needs to be expressed in the
newly formed mesoderm. To express mirn23a after early mesoderm was formed, we first differ-
entiated wildtype ESCs into EBs for 3d without viral infection. EBs were then disaggregated
into single cell suspension and infected with control (MSCV) retrovirus or the mirn23a-
expressing virus. EBs were reformed by hanging drop and allowed to differentiate for addition-
al 5 days. Contribution of the infected cells (GFP+) to the CD41+ HPC population was then as-
sayed by flow cytometry. Expressing the mirn23a cluster at a later stage in development
significantly enhanced the development of CD41+ HPCs (Fig. 7D). Three independent trans-
ductions/ differentiations were performed demonstrating that mirn23a expression increased
HPCs production (P<0.008) (Fig. 7E).
Expression of MiR-24 target Trib3 inhibits hematopoietic development of
ESCs
Trib3 is a validated target of miR-24 in vascular smooth muscle cells [31]. Misregulation of
Trib3 has the potential to influence hematopoietic differentiation through the BMP4/ Smad
Pathway [32–34, 36]. To determine if miR-24 targeting of Trib3 plays a role in the early hema-
topoiesis, we examined expression of Trib3 in d4 miR-24 KD EBs. Consistent with Trib3 being
a miR-24 target we observed a 2 to 3 fold increase in Trib3 mRNA in miR-24 KD EBs com-
pared to controls (Fig. 8A, P<0.00002). Additionally, Trib3 has the opposite expression pattern
in d4 fractionated EBs compared to miR-24(Fig. 8B). Trib3 is expressed highest in the non-me-
soderm fraction, whereas miR-24 is more highly expressed in the T+ mesoderm fractions. To
test whether this overexpression of Trib3 contributes to the block in hematopoietic develop-
ment observed in miR-24 KD EBs, we expressed Trib3 in wildtype ESCs at the onset of differ-
entiation, and assayed HPC development 6d later. Trib3 was expressed in ESCs via retroviral
transduction of cells freshly withdrawn from LIF. Infected cells were identified by co-
expression of GFP. HPC generation as evaluated by CD41 expression was reduced almost 2-
fold by expression of Trib3 compared to ESCs infected with control virus (P<0.001, Fig. 8C,
8D). A similar inhibition of EB hematopoiesis was observed if we infected d3 EBs with Trib3
retrovirus, and then examined the CD41+ population after 5 additional days of EB culture
(S6 Fig.). Additionally if we knocked down Trib3 expression in ESCs with lentiviral delivered
shRNA, we observed the opposite effect on hematopoiesis. EBs derived from Trib3 shRNA-
expressing ESCs had an increased production of CD41+ cells, compared to EBs derived from
ESCs expressing a non-targeting shRNA (S7 Fig.).
Discussion
Using two different lentiviral vectors delivering distinct shRNAs targeting miR-24, we observed
that miR-24 is required for hematopoietic development from ESCs. The absence of hemoglobi-
nized cells and greatly reduced expression of hematopoietic transcription factors Sfpi1 and
Gata1 indicate that blood development is greatly impaired in EBs generated from miR-24 KD
ESCs. Flow cytometry revealed that miR-24 is required early in development as we observed a
reduction in the number of CD41+ HPCs developing within EBs when miR-24 is antagonized.
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Fig 8. Expression of miR-24 target Trib3 impairs hematopoietic development of ESCs. A) Trib3 gene expression in d4 EBs derived from the indicated
ESC clones. The increase in expression observed in the miArrest-24 clones compared to uninfected and miArrest-SCR infected RW4 cells was significant
with a P value of<0.00002 as determined by unpaired t-test. B)Relative Trib3 mRNA expression as determined by Q-RT-PCR of RNA isolated from d4 EBs
fractionated as describe in Fig. 7. C) ESCs were taken out of LIF and spin-infected with either MigR1 or MigR1-Trib3 virus for 1.5h. Cells were then cultured
as hanging drops for 48h to form EBs. EBs were then transferred to liquid culture and grown and additional 6d before flow cytometry analysis. Surface
expression of the HPCmarkers CD41 and cKit were examined on GFP+ cells.D) Three independent infections were performed and the average percent of
CD41+ HPCs observed is shown. The decrease in CD41+ cells induced by Trib3 expression is significant with a P value of<0.001.
doi:10.1371/journal.pgen.1004959.g008
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Consistent with the flow cytometry, we detect reduced expression of transcription factors es-
sential for early hematopoiesis: Scl, and Runx1.
The defect in hematopoiesis is not due to a general inability of the miR-24 ESCs to differen-
tiate. ESCs with antagonized mR-24 express endoderm, ectoderm, and mesoderm genes nor-
mally compared to control ESCs. Cell surface expression of FLK1, and PDGFRα indicates that
lateral plate, and paraxial mesoderm is made in knockdown cells.
However decreased expression of Twist1 in miR-24 KD EBs suggests that there is a reduc-
tion in lateral plate mesoderm. This may be due to the decreased production of the lateral plate
derived blood cells. Lateral plate mesoderm also gives rise to vasculature and cardiac tissue. We
observed no deficits in the generation of cardiac tissue. Vascular development may be slightly
impaired as we observe an early decrease in expression of the endothelial gene Pecam1 and a
slight decrease in class 4 sprouts in an EB vascular sprout assay. Due to the decreased expres-
sion of Scl, it was surprising that we did not observe enhanced cardiac muscle development. Scl
has been demonstrated to be a repressor of early cardiac muscle development [44, 45]. Howev-
er, only overexpression of Scl has been reported to affect ESC cardiac development. Loss of Scl
resulted in increased cardiac differentiation in vivo in the mouse, but this may differ from re-
duced expression we see in our system. In addition, our assay may not be sensitive enough to
detect changes in cardiac development. However, since we see a dramatic impairment in HPC
production, but little or no impairment of other mesoderm derived tissue the data demon-
strates that miR-24 is not needed generally for differentiation.
The phenotype we observed from miR-24 KD ESCs cells suggest an early requirement for
miR-24 in embryonic hematopoiesis, potentially in the development or function of the heman-
gioblast. Results from the BL-CFC assays suggest that miR-24 is not required for the commit-
ment of mesoderm to the hemangioblast, as we did not observe a requirement for miR-24 in
BL-CFC generation. However, the decreased expression of Etv2, and Runx1, along with the
dramatic reduction in Scl suggests that there is a defect in differentiation downstream of the
hemangioblast. Expression of endothelial genes Pecam1, and Cdh5 was unaffected in miR-24
KD BL-CFC suggesting a potential defect in the development of hemogenic endothelium from
the BL-CFC, or a defect in the ability of hemogenic endothelium to produce HPCs.
MiR-24 was previously shown to target Trib3 in vascular smooth muscle cells [31]. Consis-
tent with it being a miR-24 target in EBs, Trib3 levels increase in d4 miR-24 KD EBs. Addition-
ally Trib3 expression goes down with mesoderm commitment in wildtype EBs, as miR-24
levels go up. To determine if increased Trib3 contributes to the phenotype we retrovirally
transduced differentiating wildtype ESCs with Trib3 retrovirus to mimic the overexpression
seen in miR-24 KD ESCs cells. Trib3 expression significantly inhibited production of HPCs
from infected ESCs compared to ESCs infected with control virus. The inhibition of hemato-
poiesis is not as dramatic as what is observed with the antagonism of miR-24, however it sug-
gests that Trib3 downregulation contributes to miR-24’s ability to promote early
hematopoiesis. Consistent with Trib3 being a negative regulator of hematopoiesis, we observed
an increase in CD41+ HPC production when Trib3 was antagonized in ESCs.
Trib3 is a member of the Tribbles family of proteins, which includes Trib1, and Trib2. Trib3
is a negative regulator of the serine threonine kinase Akt [46]. In the zebrafish embryo, PI3K/
Akt signaling is necessary for hematopoiesis and angiogenesis [47]. Additionally, Trib3 nega-
tively regulates Smurf1, the E3 ubiquitin ligase, which targets Smads 1 and 5 proteins for de-
struction [31, 32]. BMP signaling through Smads is critical component of the gene regulatory
network that drives early hematopoietic differentiation. Smad1 is required specifically at differ-
ent stages of early development of mesoderm into hematopoietic progenitors with increased
expression of Smad1 in nascent ESC derived mesoderm increasing the development of heman-
gioblast, whereas increased expression in the hemangioblast and/or hemogenic endothelium
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blocks hematopoietic differentiation [33, 36]. The distinct temporal effects of Smad1 on hema-
topoiesis are similar to what we observe with miR-24, which will inhibit hematopoiesis when
expressed at the beginning of ESC differentiation, but increases hematopoiesis when expressed
at d3 of differentiation. Increased Trib3 in miR-24 KD ESCs may disrupt BMP signaling inhib-
iting development of HPCs. It will be important to determine if disruption of PI3 kinase and/
or Smad signaling contributes to the block in hematopoietic development we observe. Identifi-
cation of other targets of miR-24 that may be upregulated in EBs to block hematopoiesis is
also critical.
Previous to this study no miRNA had been observed to regulate hematopoiesis at this early
point in mammalian ontogeny. However, a requirement for miRNAs in embryonic hematopoi-
esis was recently shown in Xenopus [30]. Morpholino knockdown of the microprocessor com-
plex member Dgcr1 results in a global knockdown of mature miRNAs in the Xenopus embryo,
and ablates production of the hemangioblast and hemogenic endothelium as evaluated by de-
creased expression of Runx1 and Flk1. Candidate miRNAs in regulating embryonic hemato-
poiesis were identified by examining miRNAs enriched in AGMHPCs isolated from the d11.5
mouse embryos. As a secondary screen, AGMHPC miRNAs were subjected to bioinformatics
analysis to determine if any of these miRNA genes had ChIP-seq peaks for hematopoietic tran-
scription factors binding within 5 kb of the pre-miRNA locus. The top candidate in this screen
was miR-142. Interestingly in their analysis miR-24 was enriched in the AGMHPCs, and was
the third top ranked miRNA gene in the ChIP-seq analysis. Expression of a mature miR-142,
but not miR-24 was able to rescue hemangioblast development in Dgcr1 knockdown embryos,
however miR-142 was unable to rescue hemogenic endothelium development. These results
appear consistent with what we have observed that miR-24 is not required for hemangioblast
development, but is needed for subsequent hematopoietic differentiation.
Understanding the gene regulation network of stem cells is critical for the development of
protocols for directing the differentiation of stem cells into tissues needed for transplant. Un-
fortunately, it is still difficult to match donors with transplant recipients, with many patients
unable to obtain life-saving tissue that is needed. The generation of induced Pluripotent Stem
Cells (iPSCs) from adult cells holds the promise of generating abundant patient specific tissues
for transplant [48–50]. Efficient and robust iPSC differentiation, or possibly other patient-
derived adult stem cells could lead to production of hematopoietic stem cells (HSCs) for trans-
plantation therapy to treat hematological disorders. MiRNAs are attractive drug targets due to
their small size, which may make them amenable to making small molecule mimics as well as
making antagonists [51]. MiR-24 is the first miRNA to be involved in this early step of differen-
tiation of mammalian mesoderm to tissue that will give rise to HPCs. Manipulating miR-24 or
its downstream targets potentially could be used for directing the differentiation of nascent me-
soderm produced from pluripotent stem cells.
Materials and Methods
Lentivirus and retrovirus production
ShRNA antagonist of miR-24 (miArrest miRNA inhibitor) or scrambled non-targeting shRNA
was expressed in a lentiviral vector co-expressing mCherry and puromycin resistance (Gene-
Copoeia, Rockville, MD). For supplementary experiments miR-ZIP vectors to deliver an inde-
pendent miR-24 targeting shRNA and scrambled shRNA were used (System Biosciences,
Mountain View, CA). pLKO.1 lentiviral plasmids expressing Trb3 ShRNA antagonists were
obtained from Thermo Scientific (Waltham, MA). pVSV-G, pMDL, and pRSV-REV plasmids
(National Gene Vector Biorepository, Indianapolis, IN) were co-transfected with lentiviral
plasmid into 293FT cells with Lipofectamine 2000 Transfection Reagent (Invitrogen, San
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Diego, CA). For retroviral production MigR1-EGFP, MigR1-Trib3, MSCV-EGFP, and MSCV-
mirn23a retroviral plasmids were co-transfected into 293FT cells together with the retroviral
packaging vector pCL-Eco (Imgenex) using Lipofectamine 2000 (Invitrogen). For both lentivi-
rus and retrovirus production 48h and 72h post-transfection viral supernatants were harvested
and concentrated with Centricon Plus-70 filters (Millipore). MigR1-Trib3 plasmid was kindly
provided by Dr. Keyong Du, Tufts University, Boston, MA.
Embryonic stem cells
RW4 ESCs (ATCC, Manassas, VA) were adapted from growth on mitomycin C-treated MEFs
to growth on plates coated with 0.1% porcine skin gelatin (Sigma, St. Louis, MO). After passag-
ing 3 times on gelatinized plates, cells were frozen or immediately used for viral infections.
RW4 ESCs were maintained on gelatin coated plates in DMEM (Invitrogen, Carlsbad, CA),
15% fetal bovine serum (FBS, Hyclone, Pittsburgh, PA), 50 U/ml penicillin, and 50 ug/ml strep-
tomycin, 1 X Non Essential Amino Acids, 2mM Glutamax, 55 μM 2-mercaptoethanol (BME),
and 1000U/ml LIF (ESGRO, Millipore, Billerica, MA). Dulbecco’s Modified Eagle Medium
(DMEM) and media additives unless otherwise indicated were obtained from Invitrogen
(Carlsbad, CA). Gelatin adapted GFP-Brachyury ESCs were obtained from Valerie Kouskoff
(Cancer Research UKManchester Institute), and were cultured as the RW4 cells.
Differentiation of ESCs
Embryoid bodies were generated from ESCs by either liquid culture or methylcellulose culture.
For liquid culture ESCs were washed out of LIF containing media, and plated onto 10 cm petri
plates (Fisher Scientific, Pittsburgh, PA) at 10,000 cells/ml in ESC media without LIF (Differen-
tiation media). ESCs were harvested at the indicated times. For methylcellulose differentiation,
10,000 ESCs were washed out of LIF and subsequently cultured in 1.5 ml 0.9% methylcellulose-
base medium (Stem Cell Technologies, Vancouver, CA) supplemented with 10% FBS
(Hyclone), 5% protein-free hybridoma medium-II (Invitrogen, Carlsbad, CA), mIL-1
(5 ng/ml), mIL-3 (5 ng/ml), SCF (10 ng/ml), mGM-CSF (5 ng/ml) and hEPO (3 U/ml) at 37°C
and 5% CO2 for 14 days. All cytokines were obtained from Invitrogen except for hEPO, which
was obtained from Stem Cell Technologies.
Vascular sprout assays
2000 ESCs/ 35mm dish were differentiated into EBs for 11 days in 1.0% Base Methylcellulose
(M3120, Stem Cell Technologies, Vancouver, CA), 15% FBS (Hyclone), 10ug/ml insulin (Sigma,
St. Louis, MO), 100ug/ml mFGF2 (Invitrogen, Carlsbad, CA), 50ug/ml VEGF (Biolegend, San
Diego, CA), 10 ng/mL mIL-6 (Invitrogen, Carlsbad, CA), 2 U/mL hEPO (Stem Cell Technolo-
gies, Vancouver, CA), 450 μMmonothioglycerol (MTG, Sigma, St. Louis, MO). 125 d11 EBs
were plated onto 35mm plates in ES-Cult Endothelial Collagen Medium (Stem Cell Technolo-
gies, Vancouver, CA) containing 50 ng/ml mVEGF, 100 ng/ml mFGF2, 10 ng/mL mIL-6, and
2 U/mL hEPO. Sprout formation was assessed 4 days later. EBs were scored in blinded fashion
according to 4 standard classes based on vascular sprout formation: I- no sprout formation,
II- few sprouts, III- many sprouts but no network, IV- many sprouts with network [41].
Cardiac differentiation assays
EBs were initially generated by hanging drops. ESCs were plated 25,000-cells/ ml in ESC media
minus LIF in 20ul drops hanging from an inverted 15cm plate lid. The 15cm plate contained
10ml H20 to keep the chamber humidified. EBs were cultured for 5d, and then individual EBs
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were transferred to an individual well of a 96 well tissue culture plate. After 5d of culture, each
well was examined for the presence of beating cells indicating the presence of cardiac tissue.
BL-CFC assay
Primary EBs were generated from ESCs by liquid culture onto 10 cm non-tissue culture petri
plates (Fisher Scientific, Pittsburgh, PA) at 5,000 cells/ml in Iscove’s Modified Dulbecco Medi-
um (Life Technologies, Grand Island, NY) supplemented with 15% differentiation fetal bovine
serum (Stem Cell Technologies, Vancouver, BC, Canada), 5% protein-free hybridoma medi-
um-II (Life Technologies), 200 ug/mL iron-saturated holo-transferrin (Sigma, St Louis, MO),
50 ug/mL ascorbic acid (Sigma), 450 uM monothioglycerol (Sigma), 2mM glutamine(Life
Technologies) and 100ug/mL penicillin/streptomycin (Life Technologies). Primary EBs was
differentiated at 37°C and 5% CO2 for 2–4 days.
At d2.75 or d3, the primary EBs from liquid culture were harvested and digested with Accu-
max (Millipore, Billerica, MA) and further dissociated into single cell suspension by passaging
with a p200 pipet tip several times. For hemangioblast assays, 12,500 cells/mL in 35mm dishes
were differentiated into BL-CFC colonies for 3–4 days in 0.9% Base Methylcellulose (M3120,
Stem Cell Technologies, Vancouver, CA) supplemented with 10% differentiation fetal bovine
serum (Stem Cell Technologies, Vancouver, BC, Canada), 200 ug/mL iron-saturated holo-
transferrin (Sigma, St Louis, MO), 50 ug/mL ascorbic acid (Sigma), 450 uMmonothioglycerol
(Sigma), 2mM Glutamax (Life Technologies, Grand Island, NY), 100ug/mL penicillin/strepto-
mycin (Life Technologies), 20% D4T endothelial cell conditioned media (Gift from Diana
Ramirez, Case-Western University, Cleveland, OH), 100 ng/mL SCF (Life Technologies) and
5ng/mL VEGF (Biolegend, San Diego, CA). BL-CFC colonies were assessed 3–4 days later.
For gene expression analysis 20 BL-CFCs per genotype were picked at d4 of differentiation
into PBS and pelleted by centrifugation. Cells were lysed, and used for preparation of cDNA
with a Cells-to-Ct kit (Ambion) according to manufacturers instructions. The cDNA was then
subjected to quantitative PCR using gene specific primers and fluorescently labeled probe as
described below.
Hematopoietic colony assay
ESCs were differentiated into EBs by methylcellulose culture as described above. After 9 days,
EBs were harvested and disaggregated with trypsin and mechanical shearing with a 21-gauge
needle. Cells were then replated into Methocult GF 3434 methylcellulose media (Stem Cell
Technologies). The number of cells plated was equal to the number of cells in 50 EBs derived
from wild-type ES cells. Number and colony type was enumerated 7 days later.
Viral infection of ESCs
For miR-24 knockdown studies, RW4 ESCs were plated at 100,000 cells per well of a 6 well
plate 24h pre-infection. The next day media was replaced with 1.5ml ESC media containing
lentivirus. Cells were spin infected for 1.5h. Media was replaced the next day. 48h post-infec-
tion cells were split onto 10cm plates in ESC media containing 5ug/ml puromycin (Invitrogen,
Carlsbad, CA). Ten to 12 days later resistant, colonies were isolated. Clones were tested for
knockdown of miRNA expression using miR-Taqman assays as described below.
For retroviral infection of ESCs, cells were trypsinized and washed out of LIF containing
media with PBS (2.7mM KCl, 1.8mM KH2PO4, 137mMNaCl, 10mMNa2HPO4, pH 7.4).
50,000 cells were replated in 1.5 ml of differentiation media containing retroviral supernatant
and centrifuged at 2125 x g for 90 minutes. 1.5 ml of differentiation media was added to the
cell. The cell suspensions were then used to form EBs by the hanging drop method. All 3mls of
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cell suspension were plated as 20ul drops on an inverted 15cm tissue culture plate lid. The lid
was then replaced onto a petri plate and incubated in the tissue culture incubator for 2 days to
allow for formation of EBs. After 2d the EBs were transferred to a 10 cm petri plate containing
7 ml of differentiation media. EBs were cultured for an additional 4 days, and differentiation as-
sayed by flow cytometry.
For infection of EBs cells, single cell suspensions were prepared from d3 EBs prepared in liq-
uid culture as described above. EBs were washed in PBS and disaggregated into single cell sus-
pensions by incubating with 1ml of Accumax (Millipore, Billerica, MA) at 37°C for 30 minutes.
To further break up the EBs, the cell solution was pipetted up and down in a 2ml pipet with a
p200 tip at the end. Cells were spun down and resuspended in 1.5 ml of differentiation media.
EB cells were then virally infected and reformed into EBs by hanging drop as described above.
EBs were examined for hematopoietic differentiation after 5 days.
Quantitative Reverse-Transcriptase Polymerase Chain Reaction
(Q-RT-PCR)
Total RNA was prepared using TRIzol (Life Technologies, Grand Island, NY) according to the
manufacturer’s protocol. For mRNA gene expression complementary DNA (cDNA) was pre-
pared by reverse transcribing 1ug of total RNA using the High Capacity cDNA Reverse Tran-
scriptase Kit according to manufacturer’s protocol (Life Technologies). Gene specific primer
sets with fluorescent probes were obtained from IDT (Coralville, IA). ΔΔCT calculations were
used to normalize signal versus GAPDH as the control. For miRNA analysis, we used miR-
specific reverse transcription primers and Taqman primers obtained from Life Technologies.
Expression level of miR-24 was normalized to sno202 snRNA expression. All experiments
were performed in triplicate using BioRad CFX96 C1000 System (BioRad, Hercules, CA).
Flow cytometry
EBs were pelleted by centrifugation and washed with PBS. EBs were disaggregated by the addi-
tion of 1ml Accumax cell dissociation buffer (Millipore, Billerica, MA) and incubated at 37°C
for 30 minutes. Single-cell suspensions were collected and washed with PBS and incubated
with the indicated antibodies. CD41-PE, FLK1-PE, ckit-APC, PDGFRα-biotin, and avidin-
APC-Cy7 were obtained from Biolegend (San Diego, CA). Stained cells were subsequently as-
sessed using Beckman Coulter FC500 Flow Cytometer (Brea, CA) and data was analyzed using
Flowjo software (Tree Star, Ashland, OR).
Supporting Information
S1 Fig. MiArrest-24 shRNA infection decreases the expression of miR-24 miRNA. A) Ex-
pression of miR-24 in undifferentiated RW4 clones infected with MiArrest-Scr (scrambled
shRNA) or miArrest-24 (shRNA antagonizing miR-24) B) Average miR-24 expression in
miArrest-Scr, and miArrest-24 infected ESC clones at the indicated days of differentiation (Re-
moval of LIF). C) Average expression of mirn23a cluster miRNAs in undifferentiated miArrest-
Scr, and miArrest-24 infected ESC clones.
(TIF)
S2 Fig. Hematopoietic colonies production form Embryoid Bodies. Single cell suspensions
were prepared from 9d EBs. Cells corresponding to 50 EB equivalents were plated into methyl-
cellulose containing hematopoietic cytokines (Methocult M3434, Stem Cell Technology). He-
matopoietic colonies were counted and scored 7d later. Data is average colony numbers
obtained from 4 independent scrambled shRNA clones, and 3 miR-24 shRNA clones.
(TIF)
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S3 Fig. Antagonizing miR-24 is ESCs with a distinct shRNA delivered by miRZIP vectors
results in a hematopoietic defect. A)MiR-24 expression in undifferentiated miRZIP-miR-24
shRNA ESC clones (24–6, 24–7) compared to ESC clone (SCR-2) infected with miRZIP vector
coding for a scrambled non-targeting shRNA. B) 14d methylcellulose differentiation of the in-
dicated miRZIP clones into EBs. C) Flow cytometry analysis of CD41 and cKit cell surface ex-
pression on single cells isolated from 6d EBs generated from the indicated ESC clones.
(TIF)
S4 Fig. Time course of development of CD41+ HPCs from RW2 and miArrest-24 infected
ESCs. Flow cytometry analysis of CD41 and ckit cell surface expression on single cell suspen-
sions prepared from EBs. Single cell suspensions were prepared from EBs derived from RW4,
or a miArrest-24 infected ESC clones isolated at d3, d4, d5, and d6 post removal of LIF.
(TIF)
S5 Fig. Fractionation of d4 EBs. ESCs with GFP knocked in to the T locus (Brachyury) were
differentiated for 4d into EBs. The EBs were dissociated into single cells suspensions, and
sorted into GFP-Flk1-, GFP+Flk1-, and GFP+Flk1+ fractions. The GFP versus Flk1 FACs plot
shows the 3 gates of cells that were collected. To verify that the fractions were sorted properly
Q-RT-PCR was performed on RNA isolated from the fractionated cells. Gene expression
agreed with previously published data using this ESC line [11].
(TIF)
S6 Fig. Trib3 impairs hematopoietic development when expressed at d3 of EB differentia-
tion. A) Single cell suspensions were prepared from d3 EB cells and infected with MigR1 con-
trol or MigR1-Trib3 retrovirus. EBs were reformed by hanging drop, and cultured an
additional 5 days. Contribution of the infected (GFP+) cells to the HPC population CD41+,
and CD41+cKit+ was evaluated by flow cytometry. Results from 2 independent infections/ dif-
ferentiations are shown.
(TIF)
S7 Fig. Knockdown of Trib3 enhances hematopoietic differentiation. RW4 ESCs were in-
fected with empty vector (pLKO.1), Trib3 shRNA (KD), or non-targeting shRNA expressing
lentiviruses. Infected cell clones were generated by selection in puromycin. 1 pLKO.1, 2 inde-
pendent Trib3 shRNA, and 1 non-targeting (NT) clones were examined. A) Quantitative RT-
PCR assaying Trib3 expression in the isolated clones. B) Flow cytometry analysis of CD41 and
cKit (CD117) cell surface expression on single cells isolated from EBs generated from the indi-
cated ESC clones. CD41+cKit- population contains primitive HPCs and CD41+cKit+ popula-
tion contains primitive and definitive HPCs.
(TIF)
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